Free Trial

Anpario plc (LON:ANP) Insider Sells £53,200 in Stock

Anpario logo with Consumer Defensive background

Anpario plc (LON:ANP - Get Free Report) insider Karen Prior sold 14,000 shares of the stock in a transaction dated Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.82), for a total value of £53,200 ($67,495.56).

Anpario Price Performance

Shares of LON ANP remained flat at GBX 385 ($4.88) during mid-day trading on Monday. The company had a trading volume of 32,758 shares, compared to its average volume of 32,714. Anpario plc has a 1-year low of GBX 220 ($2.79) and a 1-year high of GBX 394.50 ($5.01). The firm has a market cap of £65.10 million, a PE ratio of 2,138.89 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm's 50 day simple moving average is GBX 329.93 and its 200 day simple moving average is GBX 310.02.

Analyst Ratings Changes

ANP has been the topic of several research analyst reports. Canaccord Genuity Group lifted their price objective on Anpario from GBX 340 ($4.31) to GBX 370 ($4.69) and gave the company a "buy" rating in a research note on Wednesday, September 18th. Shore Capital reissued a "house stock" rating on shares of Anpario in a research report on Wednesday, September 11th.

Read Our Latest Stock Analysis on ANP

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Should you invest $1,000 in Anpario right now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Amazon is set to continue its dominance in 2025, fueled by its robust e-commerce platform and the unmatched power of AWS in the data center space.

Related Videos

Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines